Topics

Preserving Clinical Trial Integrity During the Coronavirus Pandemic

20:00 EDT 24 Mar 2020 | JAMA

This Viewpoint discusses ways the coronavirus pandemic is threatening clinical trial conduct and enrollment, and suggests ways to adapt, including changes to how outcomes data are collected and how interventions are delivered and monitored, to minimize trial disruption, maximize trial benefit, and ensure patient health and safety during the pandemic.

Original Article: Preserving Clinical Trial Integrity During the Coronavirus Pandemic

NEXT ARTICLE

More From BioPortfolio on "Preserving Clinical Trial Integrity During the Coronavirus Pandemic"

Quick Search

Relevant Topic

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...